This project aims to strengthened Thai health system post COVID times and has been started since 1 April 2022 until the end of March 2023. There are five sub-projects under the grant consisting of environmental health, local governance, health financing, and digital technology.post COVID

In 2016 Bhutan graduated from Gavi support as its socioeconomic status change from lower-income to lower-middle income country, hence introducing new vaccines to its routine vaccination programme can pose a long-term financial burden to the government. However, since pneumococcal infections is a maj

In the Prince Mahidol Award Conference 2026 (PMAC 2026), held from January 26–31, 2026, at the Centara Grand & Bangkok Convention Centre at CentralWorld, the Health Intervention and Technology Assessment Program Foundation (HITAP) participated in supporting and driving the international exchange

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

More dentists need to be checking their patients for mouth cancer, say experts.Cancer Research UK says oral cancer rates are going up and some dentists are missing an opportunity to spot those at risk.All dentists should be asking about risk factors like smoking or heavy drinking as well as early te

A new oral medication to treat patients in the early stages of multiple sclerosis has shown considerable promise in two clinical trials, researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S. patients, and potentially the safest and most ef

In early 2019, the Philippines passed a Universal Health Coverage (UHC) Act that automatically enrolls all Filipino citizens in a national health insurance scheme under the Philippine Health Insurance Corporation (PhilHealth). P0F0F1 P Their aim, to improve the breadth and depth of healthcare cove

Investors cheered the news, sending shares of the drugmaker soaring 50 percent to $4.59 on the Nasdaq on Friday afternoon.The Phase 2 trial, involving 121 previously treated non-small cell lung cancer patients, found that those given a lower dose of bavituximab plus chemotherapy lived for a median o

ROONGNAPA KHAMPANG1,2, SAWITRI ASSANANGKORNCHAI1 & YOT TEERAWATTANANON2 1Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, HatYai, Songkhla, Thailand, and 2Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Tha

Parntip Juntama is a Researcher at HITAP specializing in Health Technology Assessment (HTA) and Health Economics. Her work focuses on policy-related research that provides evidence to support healthcare policy decisions in Thailand.Research Focus:Parntip conducts research on various health policy topics to inform national public health strategies.